Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The main objectives of the trial are to study whether daily treatment with liraglutide
improves insulin secretion and glucose metabolism, and whether liraglutide treatment is
tolerable and safe in subjects with preclinical type 1 diabetes aged 18-30 years.
Phase:
Phase 2
Details
Lead Sponsor:
University of Oulu
Collaborators:
Oulu University Hospital Tampere University Hospital Turku University Hospital